Nine-pharma "hydrochloric acid left cytiline capsules" through the generic drug consistency evaluation.

Guide: Nine ClassicS Pharmaceuticals is the first enterprise in China to evaluate the consistency of the capsules of cesitine hydrochloric acid. on August 8,
, Hunan Jiuxian Pharmaceutical Co., Ltd. announced that it had recently received the "Notice of Approval of Supplementary Drug Applications" issued by the State Drug Administration, and that the company's products "Cxiitiquine capsules hydrochloric acid" were evaluated for the quality and efficacy of generic drugs.
hydrochloride zositiline capsules are used to treat allergic rhinitis (including seasonal persistent allergic rhinitis and perennial persistent allergic rhinitis) and chronic irritific urticaria. The incidence of allergic diseases in
is increasing year by year worldwide, and survey data from the World Organization for Allergy (WAO) show that epidemiological surveys of 1.2 billion people in 30 countries show that 250 million people (22%) suffer from allergic diseases and 37.3% of allergic diseases in China.
hydrochloric acid zositillin tablet original development agent by UCB company in 2001 first listed in Germany, and then listed in the United Kingdom, the United States, France and other countries.
its antihistamine activity is better than cytrylicin, in clinical anti-allergic rhinitis is better than chlorpyrifos;
since 2004, the domestic has approved the hydrochloric acid zositillin raw materials, tablets, capsules, oral solutions on the market.
studies have shown that the DDC value of cesitatinhydrochloride is moderate, easy for patients to accept and is clinically popular.
Nine-Nine Pharmaceuticals is the first enterprise in China to evaluate the consistency of hydrochloric acid zositilynia capsules.
.